Table 1

Baseline characteristics

CADP valuePADP value
Age (years)64.4±10.464.9±10.20.65865.4±9.366.7±9.90.442
Male gender (%)
Diabetes duration (years)5.0±7.07.1±8.7
Hypertension (%)
Smoking (%)
Body mass index (kg/m2)27.0±3.928.8±4.5<0.00126.2±4.328.3±4.9<0.001
Waist circumference (cm)96±11102±11<0.00196±13103±14<0.001
HbA1c (%)5.7±0.37.2±1.3<0.0015.6±0.37.2±1.5<0.001
Triglycerides (mg/dL)139±90175±103<0.001135±78162±1000.180
Total cholesterol (mg/dL)213±46204±470.005192±39182±520.160
LDL cholesterol (mg/dL)137±40126±39<0.001119±36111±440.240
HDL cholesterol (mg/dL)55±1649±14<0.00157±1848±15<0.001
Apolipoprotein A1 (mg/dL)154±28147±270.001163±33148±34<0.001
Apolipoprotein B (mg/dL)99±29100±300.47682±2184±290.934
Systolic blood pressure (mm Hg)137±19139±200.346141±22143±250.421
Diastolic blood pressure (mm Hg)81±1081±120.63880±1181±140.898
Statins (%)
ACE inhibitors/ATII RBA (%)36.847.60.00345.661.80.006
Beta receptor blocking agents (%)50.746.30.24534.943.10.156
Aspirin or clopidogrel (%)
  • To convert values for fasting plasma glucose to mmol/L multiply by 0.0555, to convert values for triglycerides to mmol/L multiply by 0.0113 and to convert values for total cholesterol, LDL cholesterol or HDL cholesterol to mmol/L multiply by 0.0259. Data are shown as means±SD if not denoted otherwise.

  • ACE, angiotensin converting enzyme; ATII RBA, angiotensin II receptor blocking agents; CAD, coronary artery disease; HbA1c, hemoglobin A1c; HDL, high density lipoprotein; LDL, low density lipoprotein; PAD, peripheral artery disease; T2DM, type 2 diabetes mellitus.